Medical Patent News

RSS

Starpharma's VivaGelR patent approved in Japan

Starpharma Holdings Limited today announced that one of its key patents relating to the use of dendrimers to protect against sexually transmitted infections has been approved in Japan.

29 Oct 2008

Memory Pharmaceuticals issued key U.S. patent for series of nicotinic alpha-7 receptor agonists

Memory Pharmaceuticals Corp. has announced the issuance of U.S. Patent No. 7,429,664, which provides composition of matter patent protection for a series of nicotinic alpha-7 receptor agonists.

27 Oct 2008

Mylan confirms generic Lescol patent challenge

Mylan Inc. has confirmed that the company and its subsidiary, Mylan Pharmaceuticals Inc., have been sued by Novartis in connection with Fluvastatin Capsules USP, 20 mg (base) and 40 mg (base), the generic version of Novartis' Lescol(R) Capsules.

22 Oct 2008

Barr Laboratories confirms Opana ER tablet patent challenge

Barr Pharmaceuticals, Inc. today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Endo Pharmaceuticals Inc. in connection with its Opana(R) ER (oxymorphone hydrochloride) extended-release tablets, 5 mg, 10 mg, 20 mg and 40 mg.

22 Oct 2008

Ocimum Biosolutions awarded two U.S. patents for gene expression technology

Ocimum Biosolutions has announced issuance of United States Patent No. 7,428,554 which covers the company's proprietary system and method for determining matching patterns within gene expression data and US Patent No. 7426441, which covers methods for determining renal toxins.

15 Oct 2008

neuMirRx issued U.S. patent for "methods for enhancing solubility of compounds

neuMirRx Corp today welcomed the issuance of U.S. patent 7,345,093, entitled "Methods for Enhancing Solubility of Compounds" which covers novel formulation methods to enhance the solubility of hydrophobic compounds.

15 Oct 2008

Aperio awarded patent for use of TDI arrays in microscope slide scanners

Aperio Technologies, Inc. announced today that the United States Patent and Trademark Office has issued the company patent No. 7,428,324 entitled "System and Method for Data Management in a Linear-array based Microscope Slide Scanner."

13 Oct 2008

Micronics receives two new patents on microfluidic technologies

Micronics, Inc. today announced that it has been issued two patents from the United States Patent and Trademark Office (USPTO) for novel microfluidic devices and methods. These new patents relate to the company’s focus on the development of rapid and easy to use clinical diagnostic products.

29 Sep 2008

Corgenix receives third U.S. patent on AtherOx technology

Corgenix Medical Corporation has received notification of U.S. Patent Office approval for technology to which Corgenix holds exclusive worldwide licensing rights outside of Japan.

25 Sep 2008

Biotechnology Industry Organization says Kyl legislation advances patent reform debate

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the patent reform legislation introduced yesterday by Senator Jon Kyl (R, AZ):

25 Sep 2008

Patent for making oxygen from light and water - early stage invention is advancement toward artificial lungs

Astronauts, submariners, miners, and those suffering from lung ailments take note: Innovation is coming to the rescue. A group of scientists from Battelle has earned a patent for generating oxygen in a process that mimics photosynthesis.

25 Sep 2008

Geron issued U.S. patent for cardiomyocytes from human embryonic stem cells

Geron Corporation has announced the issuance of U.S. Patent No. 7,425,448, with broad claims to cardiomyocytes derived from human embryonic stem cells (hESCs). The patent runs until at least April 2025 (subject to any patent term extension that may be available). Geron's GRNCM1 program is developing hESC-derived cardiomyocytes for the treatment of heart disease.

16 Sep 2008

Domainex has core intellectual property rights granted for Europe

Domainex Ltd (Domainex), an innovative biopharmaceutical company, today announced the grant of European Patent No.1442134 for its Combinatorial Domain Hunting (CDH) Technology.

From Domainex 14 Sep 2008

Smart Disc issued patent for artificial spinal disc technology

Smart Disc, Inc., a Michigan-based medical technology company focused on the development of new and innovative spine products, announced today that it has been awarded Patent US 7,407,513 B2 for Smart Disc’s unique artificial spinal disc technology.

11 Sep 2008

The Quantum Group files four new provisional healthcare IT patents

The Quantum Group, Inc., a Wellington, Florida based healthcare organization, announced the filing of four new provisional patents to enhance the proprietary PWeR(TM) platform developed by the Company and to drive greater efficiencies within the healthcare industry.

10 Sep 2008

Domainex, has core intellectual property rights granted for Europe

Domainex Ltd (Domainex) today announced the grant of European Patent No.1442134 for its Combinatorial Domain Hunting (CDH) Technology.

From Domainex 10 Sep 2008

Salix commences patent infringement litigation against Novel Laboratories

Salix Pharmaceuticals, Ltd. has announced that Salix Pharmaceuticals, Inc. has filed a lawsuit in the United States District Court for the District of New Jersey against Novel Laboratories, Inc. for infringement of the patent protecting OSMOPREP (sodium phosphate monobasic monohydrate, USP and sodium phosphate dibasic anhydrous, USP) Tablets.

8 Sep 2008

Gilead's antiretroviral patent request rejected by Brazil

A patent request from the pharmaceutical company Gilead for its antiretroviral drug tenofovir was rejected by Brazil Wednesday, Reuters reports.

4 Sep 2008

Invitrogen launches patent licensing program for random prime amplification of nucleic acids

Invitrogen Corporation today announced that it has signed non-exclusive agreements with New England Biolabs, Inc., QIAGEN GmbH, and Kirkegaard & Perry Laboratories, Inc. (KPL), whereby the companies have licensed Invitrogen's patented technology covering the random prime amplification of nucleic acids. Financial terms of the agreements were not disclosed.

4 Sep 2008

Panacea Pharmaceuticals issued U.S. patent for anti-HAAH antibodies

Panacea Pharmaceuticals, Inc. has announced the issuance of U.S. Patent Number 7,413,737 covering antibodies against human aspartyl (asparaginyl) beta-hydroxylase (HAAH), a proprietary human cancer biomarker and therapeutic target.

3 Sep 2008